FREDERICK, Md., Feb. 18,
2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink:
BIEL), the maker of advanced consumer medical devices, announced
today that its ActiPatch® Musculoskeletal Pain Relief Therapy and
Smart Insole™ Heel Pain Therapy products have received award
nominations from the OTC Bulletin, the leading international trade
publication for OTC developments worldwide.
The ActiPatch® has been nominated for the "Best New OTC
Packaging Design Award" and Smart Insole™ for "Most
Innovative New OTC Product Award".
The OTC Bulletin is firmly established as the most
comprehensive and frequent source of news, views and analysis for
pharmaceutical executives in the world's leading consumer
healthcare companies in over 45 countries.
The "Best New OTC Packaging Design" and "Most
Innovative New OTC Product" awards are a few of the prestigious
awards that make up the 2014 OTC Marketing Awards. Each award
was judged by a panel of independent experts experienced and
knowledgeable in the OTC market.
"We are excited to have again been nominated for the 'Most
Innovative New OTC Product' award," said Ben Fichter, Marketing Manager. "We
believe our products will continue to be recognized and awarded as
we Change the Way People Heal and Stop Pain."
For more information and to view the nomination supplement,
please visit www.otcbulletin.com/awards.
The award presentation will take place on Thursday, March 6, 2014 in London.
About BioElectronics Corporation
BioElectronics is
the leader in consumer medical devices that reduce pain,
inflammation and accelerate healing. Its products are
ActiPatch® Musculoskeletal Pain Therapy for back, knee, and other
musculoskeletal complaints; RecoveryRx® for chronic and
post-operative wound care; HealFast® Veterinary Therapy, Allay®
Menstrual Pain Therapy and Smart Insole™ Heel Pain Therapy.
Visit www.bielcorp.com for more information.
BioElectronics Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
SOURCE BioElectronics Corporation